$ Value
$76K
Shares
900
Price
$84
Filed
Apr 3
Insider
Name
Henderson Jane
Title
Chief Financial Officer
CIK
0001422304
Roles
Transaction Details
Transaction Date
2026-04-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
178,471
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.15 to $85.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.17 to $85.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Filing Info
Henderson Jane's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-16 | APGE | ▼ | $180K |
| 2026-04-01 | APGE | ▼ | $76K |
| 2026-04-01 | APGE | ▼ | $94K |
| 2026-03-25 | APGE | ▼ | $170K |
| 2026-01-06 | APGE | ▼ | $160K |
| 2026-01-02 | APGE | ▼ | $142K |
| 2026-01-02 | APGE | ▼ | $307K |
| 2026-01-02 | APGE | A | $0 |
| 2025-12-19 | APGE | ▼ | $120K |
| 2025-12-09 | AKRO | D | — |
Other Insiders at APGE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Henderson Jane
Chief Financial Officer
|
— | $444K | 2026-04-16 |
|
HENDERSON MICHAEL THOMAS
Chief Executive Officer
|
— | $1.7M | 2026-04-16 |
|
Dambkowski Carl
Chief Medical Officer
|
— | $467K | 2026-04-01 |